← All organizations

Cipla

For profitWebsite ↗

Also known as: CIPLA | Cipla BioTec | Cipla BioTec Pvt. Ltd. | CIPLA LIMITED | Cipla Ltd. | CIPLA LTD | CIPLA USA | Cipla USA Inc. | CIPLA USA INC.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

First marketed drug

Last known activity

Apr 22, 2026

Timeline

1930s

Jun 1, 1935
Cipla— Founded

2010s

Sep 4, 2015
Invagen Pharms— Acquired
Jul 12, 2018
Mirren Pty Ltd.— Acquired

2020s

Dec 17, 2021
lanreotide— NDA Secondary Org
Apr 22, 2022
phytonadione— Marketing Organization

Drugs by trial phase (22 distinct, 12 trials)

Phase 4 (6 own, 0 via acquisition)

Phase 3 (13 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

plazomicin

Indications

Studied for

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (15)

NCT06705478CollaboratorPhase 2Jan 17, 2025
NCT06370715CollaboratorPhase 4Apr 18, 2024
NCT06154304Lead sponsorPhase 3Dec 11, 2023
NCT05322707Lead sponsorPhase 3Apr 15, 2022
NCT04699656Lead sponsorPhase 1Jan 5, 2021
NCT04699656Study directorPhase 1Jan 5, 2021
NCT03394989Lead sponsorPhase 3Feb 26, 2018
NCT02879097Study directorPhase 3Dec 1, 2016
NCT02879097Lead sponsorPhase 3Dec 1, 2016
NCT02747823Lead sponsorPhase 1Jun 1, 2016
NCT02624505Study chairPhase 3Dec 1, 2015
NCT02624505Lead sponsorPhase 3Dec 1, 2015
NCT01621321CollaboratorPhase 2/Phase 3Jun 1, 2013
NCT01373359CollaboratorPhase 3Mar 1, 2007
NCT00380770CollaboratorPhase 4Jan 1, 2003

Details

Founded: Mumbai, IN Jun 1, 1935
Last known activity: Apr 22, 2026